HCPCS Level II code J2327 describes an intravenous injection of risankizumab-rzaa, billed per 1 mg unit; this code represents administration of the biologic agent via IV infusion, typically provided in an outpatient infusion center or hospital outpatient department and documented as a medication administration service for systemic biologic therapy.